ATARA BIOTHERAPEUTICS INC's ticker is ATRA and the CUSIP is 046513107. A total of 135 filers reported holding ATARA BIOTHERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.01 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $857,000 | -2.9% | 110,000 | +15.8% | 1.04% | +102.9% |
| Q1 2022 | $883,000 | -41.0% | 95,000 | 0.0% | 0.51% | -48.4% |
| Q4 2021 | $1,497,000 | -20.4% | 95,000 | -9.6% | 1.00% | -27.4% |
| Q3 2021 | $1,881,000 | +65.6% | 105,100 | +43.9% | 1.37% | +74.6% |
| Q2 2021 | $1,136,000 | +688.9% | 73,056 | +630.6% | 0.78% | +946.7% |
| Q1 2021 | $144,000 | -66.5% | 10,000 | -54.3% | 0.08% | -78.9% |
| Q4 2020 | $430,000 | -78.6% | 21,900 | -85.9% | 0.36% | -82.8% |
| Q3 2020 | $2,009,000 | -8.1% | 155,000 | +3.3% | 2.06% | -13.1% |
| Q2 2020 | $2,186,000 | +133.5% | 150,000 | +36.4% | 2.37% | +41.0% |
| Q1 2020 | $936,000 | -35.3% | 110,000 | +25.2% | 1.68% | -30.7% |
| Q4 2019 | $1,447,000 | +70.8% | 87,873 | +46.5% | 2.42% | +185.4% |
| Q3 2019 | $847,000 | +68.4% | 60,000 | +140.0% | 0.85% | +24.7% |
| Q2 2019 | $503,000 | – | 25,000 | – | 0.68% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Antipodean Advisors LLC | 1,000,000 | $1,610,000 | 11.42% |
| Redmile Group, LLC | 6,048,123 | $9,737,478 | 0.37% |
| Baupost Group | 9,773,616 | $15,736 | 0.28% |
| JOSH ARNOLD INVESTMENT CONSULTANT, LLC | 170,000 | $273,700 | 0.27% |
| MAVERICK CAPITAL LTD | 6,290,713 | $10,128,048 | 0.22% |
| 683 Capital Management, LLC | 1,000,000 | $1,610,000 | 0.12% |
| WASATCH ADVISORS LP | 8,283,981 | $13,337,209 | 0.08% |
| PACIFIC HEIGHTS ASSET MANAGEMENT LLC | 525,000 | $845,250 | 0.08% |
| STALEY CAPITAL ADVISERS INC | 750,000 | $1,207,500 | 0.06% |
| XTX Topco Ltd | 136,841 | $220,314 | 0.04% |